AzTrials
AzTrials

Post Coronary Artery Bypass GraftingNCT05684679

Effectiveness of Incentive Spirometer and Diaphragmatic Breathing Exercise on ABG Measures in Post-CABG Patients

A study testing Incentive spirometer plus Chest physiotherapy and Diaphragmatic breathing exercise plus Chest physiotherapy in people with Post Coronary Artery Bypass Grafting, run by King Saud University at 1 site in Saudi Arabia.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The rate of pulmonary complications following Coronary artery bypass graft (CABG) is high. Early pulmonary exercises are important in preventing this complication following cardiac surgery. Read more about this study

Who is it for?
Ages 40 to 60 years
Conditions the study is for
Post Coronary Artery Bypass Grafting
What is being tested?
Incentive spirometer plus Chest physiotherapy and Diaphragmatic breathing exercise plus Chest physiotherapy
Could I receive a placebo?
No, everyone receives an active treatment
How many people
30 participants
Where
1 siteSaudi Arabia
Study dates
15 Apr 2019to 25 Aug 2019
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 40 to 60 years
  • All sexes
  • No healthy volunteers
  • Adult

Who may be able to join

  • The patient with post-CABG,
  • Aged between 40 and 60 years,
  • Had forced expiratory volume in 1 second (FEV1) <70% of predicted value,
  • Showed FEV1/forced vital capacity (FVC) ratio >0.8,
  • Weight equal or exceeded the ideal body weight by less than 20%, and
  • Patient co-operation.

Who cannot join

  • Aged more than 60 years,
  • Weight equal or exceeded the ideal body weight by more than 20%,
  • Post-operative respiratory treatment exceeding 20 hours,
  • History of Chronic obstructive pulmonary disease (COPD) /thoracic surgery including CABG,
  • had thoracic anomalies/unstable angina,
  • Developed hemodynamic complication, and
  • Non-cooperative/neurological debilitated patient.

Trial locations and contacts

1 site in 1 country.

Saudi Arabia1 site
  • Rehabilitation Research Chair, Department of Rehabilitation Sciences, king Saud University

    Riyadh, Riyadh 11433, 10219

Other trials in Saudi Arabia

About this study

Official title: Efficacy of Incentive Spirometer and Diaphragmatic Breathing Exercise on the Alteration of Arterial Blood Gas Measures in Patients After Coronary Artery Bypass Grafting. A Randomized Comparative Study

The rate of pulmonary complications following Coronary artery bypass graft (CABG) is high. Early pulmonary exercises are important in preventing this complication following cardiac surgery. This study aimed to investigate the effectiveness of incentive spirometer (IS) and diaphragmatic breathing exercise (DBE) on the alteration of arterial blood gas (ABG) measures. The study was based on a two-arm, parallel-group, randomized comparative design. Thirty patients who underwent CABG enrolled in the study based on inclusion and exclusion criteria, randomly allocated into either of the groups, IS Group or DBE Group. IS Group and DBE Group underwent chest physiotherapy with IS and DBE, respectively. ABG measures, including PH of blood, partial pressure of arterial oxygen molecule (PaO2), and partial pressure of arterial carbon dioxide (PaCO2), was assessed using an ABG analyzer at baseline (pre-operation), day1 post-operation, and day2 post-operation. The significance level was kept constant for all statistical analyses at 95%.

Read the detailed description

Coronary artery bypass graft (CABG) is one of common treatment procedures performed worldwide. Evidence suggest that every year more than 1 million CABG procedure has been performed. Pulmonary complications are one of the most common consequence post CABG.

The incidence of atelectasis after heart operation with cardiopulmonary bypass is still 80-84% in spite of careful fluid \& respiratory management. The basic problem in respiratory care of post-surgical patient is atelectasis leading to hypoxemia causing alteration in arterial blood gases (ABGs). Associated with atelectasis are widening alveolar - arterial O2 gradient (as right to left intrapulmonary shunting increases) decrease ventilation perfusion ratio, decrease functional residual capacity and decrease compliance. Chest physiotherapy is routinely used after major abdominal \& cardiothoracic surgery to prevent these pulmonary complications following operation.

To date, there is a variable view about the effectiveness of these two primary breathing exercise techniques (incentive spirometer and diaphragmatic breathing exercise). 10-12 Hence an effort to systematically study the effectiveness of these is attempted. Thus, the current study aimed to determine the efficacy of incentive spirometer and diaphragmatic breathing exercises in addition to conventional chest physiotherapy on alteration of ABG measures in patients with post CABG. This study hypothesized that there will be a significant difference between the effect of the IS and DBE on ABG alteration in post CABG patients.

Being tested
Incentive spirometer plus Chest physiotherapy, Diaphragmatic breathing exercise plus Chest physiotherapy
Keywords
Chest Physiotherapy, Incentive spirometer, Diaphragmatic breathing

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Incentive spirometer plus Chest physiotherapyOther

    Also called Huffing, Coughing, Upper and lower limbs active exercises

    Incentive spirometer was given to IS group. However, a conventional chest physiotherapy was given to both groups in the optimal position.

  • Diaphragmatic breathing exercise plus Chest physiotherapyOther

    Also called Huffing, Coughing, Upper and lower limbs active exercises

    Diaphragmatic breathing exercise was given to DBE group. In addition, a conventional chest physiotherapy was given in the optimal position.

Study groups in NCT05684679
Study groupRoleWhat they receive
IS GroupExperimental• Patients were instructed to utilize an incentive spirometer in the sitting or half lying position as taught preoperatively. * 3 to 5 consecutive breath with the spirometer were interspersed between period of quite breathing. * Duration 10-15 minutes/session.
Receives: Other: Incentive spirometer plus Chest physiotherapy
DBE GroupExperimental• Patients were advised to do diaphragmatic breathing exercise in the sitting or half lying position as taught preoperatively. * 3 to 5 consecutive deep breath were interspersed between period of quite breathing. * Duration 10-15 minutes/session.
Receives: Other: Diaphragmatic breathing exercise plus Chest physiotherapy

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. PH of Blood

    PH of blood was assessed using an ABG analyzer machine

    Measured: 3 Days

  2. Partial pressure of Arterial Oxygen molecule (PaO2)

    PaO2 was assessed using an ABG analyzer machine

    Measured: 3 Days

  3. Partial pressure of Arterial Carbon dioxide molecule (PaCO2)

    PaCO2 was assessed using an ABG analyzer machine

    Measured: 3 Days

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted13 Jan 2023
  2. Study start15 Apr 2019
  3. Primary completion30 Jul 2019
  4. Study completion25 Aug 2019

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Double blind
Who is masked
Participant, Outcomes assessor
Enrolment
30 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05684679
Sponsor's protocol ID
RRC-2019-13
Status last verified
Jan 2023
First submitted
4 Jan 2023
Last updated
18 Jan 2023
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing Incentive spirometer plus Chest physiotherapy and Diaphragmatic breathing exercise plus Chest physiotherapy in people with Post Coronary Artery Bypass Grafting, run by King Saud University at 1 site in Saudi Arabia.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 6 inclusion and 7 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 18 Jan 2023. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Saudi Arabia. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

PH of Blood (time frame: 3 Days). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 18 Jan 2023.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in